Back to mobile site
Get it on Google Play

Zai Lab and argenx report Phase 3 trial win for myositis drug

August 17, 2026 6:00 AM EDT Send to a Friend
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & NASDAQ: ARGX) announced positive topline results from the Phase 3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login